Source: Annual Congress 2010 - Experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Nikam, R. Schermuly, R. Dumitrascu, N. Weissmann, G. Kwapiszewska, W. Seeger, R. Voswinckel (Bad Nauheim, Giessen, Germany). Circulating fibrocyte recruitment and differentiation inhibited by treprostinil in pulmonary hypertension murine model. Eur Respir J 2010; 36: Suppl. 54, 1070

Member's Comments

No comment yet.

Related content which might interest you: Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1302-1314 Year: 2010 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Corticosteroids inhibit perivascular recruitment of IL-6 producing cells, maintain BMPR-II pulmonary expression and prevent pulmonary hypertension in monocrotalin-exposed rats Source: Eur Respir J 2007; 30: Suppl. 51, 347s Year: 2007 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma Source: Eur Respir J 2011; 38: 679-687 Year: 2011 Distinct patterns of circulating endothelial cells in pulmonary hypertension Source: Eur Respir J 2010; 36: 1284-1293 Year: 2010 Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model Source: International Congress 2017 – Experimental PH Year: 2017 Vascular remodelling is reversed following BMPR2 modified endothelial progenitor cell therapy in a MCT-induced PAH rat model Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results) Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Nintedanib and pirfenidone inhibit collagen synthesis and maturation at several regulatory levels Source: International Congress 2016 – ILD pathogenesis Year: 2016